|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim C, He P, Bialkowska A and Yang V: SP
and KLF transcription factors in digestive physiology and diseases.
Gastroenterology. 152:1845–1875. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun Z, Han Q, Zhou N, Wang S, Lu S, Bai C
and Zhao R: MicroRNA-9 enhances migration and invasion through
KLF17 in hepatocellular carcinoma. Mol Oncol. 7:884–894. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng JJ, Wu B, Xiao XB, Shao YS, Feng Y
and Yin MX: Reduced Krüppel-like factor 17 (KLF17) expression
correlates with poor survival in patients with gastric cancer. Arch
Med Res. 45:394–399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li S, Qin X, Cui A, Wu W, Ren L and Wang
X: Low expression of KLF17 is associated with tumor invasion in
esophageal carcinoma. Int J Clin Exp Pathol. 8:11157–11163.
2015.PubMed/NCBI
|
|
6
|
Gao SP, Sun HF, Li LD, Fu WY and Jin W:
UHRF1 promotes breast cancer progression by suppressing KLF17
expression by hypermethylating its promoter. Am J Cancer Res.
7:1554–1565. 2017.PubMed/NCBI
|
|
7
|
Gumireddy K, Li A, Gimotty PA,
Klein-Szanto AJ, Showe LC, Katsaros D, Coukos G, Zhang L and Huang
Q: KLF17 is a negative regulator of epithelial-mesenchymal
transition and metastasis in breast cancer. Nat Cell Biol.
11:1297–1304. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao HL, Zhou N, Sun Z, Dou XL, Guan M and
Bai CM: KLF17 expression in colorectal carcinoma and its clinical
significance. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 38:69–72.
2016.PubMed/NCBI
|
|
9
|
Zlobec I, Terracciano L, Jass J and Lugli
A: Value of staining intensity in the interpretation of
immunohistochemistry for tumor markers in colorectal cancer.
Virchows Arch. 451:763–769. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Crnogorac-Jurcevic T, Gangeswaran R,
Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W,
Campbell F, Brentnall T, et al: Proteomic analysis of chronic
pancreatitis and pancreatic adenocarcinoma. Gastroenterology.
129:1454–1463. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang F, Yang YZ, Shi CZ, Zhang P, Moyer
MP, Zhang HZ, Zou Y and Qin HL: UHRF1 promotes cell growth and
metastasis through repression of p16(ink(4)a) in colorectal cancer.
Ann Surg Oncol. 19:2753–2762. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamamoto Y, Hirakawa E, Mori S, Hamada Y,
Kawaguchi N and Matsuura N: Cleavage of carcinoembryonic antigen
induces metastatic potential in colorectal carcinoma. Biochem
Biophys Res Commun. 333:223–229. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koch A, Joosten SC, Feng Z, de Ruijter TC,
Draht MX, Melotte V, Smits KM, Veeck J, Herman JG, Van Neste L, et
al: Analysis of DNA methylation in cancer: Location revisited. Nat
Rev Clin Oncol. 15:459–466. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao W, Hisamuddin IM, Nandan MO, Babbin
BA, Lamb NE and Yang VW: Identification of Kruppel-like factor 4 as
a potential tumor suppressor gene in colorectal cancer. Oncogene.
23:395–402. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reeves HL, Narla G, Ogunbiyi O, Haq AI,
Katz A, Benzeno S, Hod E, Harpaz N, Goldberg S, Tal-Kremer S, et
al: Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene
frequently inactivated in colorectal cancer. Gastroenterology.
126:1090–1103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kang L, Lu B, Xu J, Hu H and Lai M:
Downregulation of Kruppel-like factor 9 in human colorectal cancer.
Pathol Int. 58:334–338. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakaya T, Ogawa S, Manabe I, Tanaka M,
Sanada M, Sato T, Taketo MM, Nakao K, Clevers H, Fukayama M, et al:
KLF5 regulates the integrity and oncogenicity of intestinal stem
cells. Cancer Res. 74:2882–2891. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu J, Lu B, Xu F, Gu H, Fang Y, Huang Q
and Lai M: Dynamic down-regulation of Kruppel-like factor 4 in
colorectal adenoma-carcinoma sequence. J Cancer Res Clin Oncol.
134:891–898. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ali A, Shah AS and Ahmad A:
Gain-of-function of mutant p53: Mutant p53 enhances cancer
progression by inhibiting KLF17 expression in invasive breast
carcinoma cells. Cancer Lett. 354:87–96. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ali A, Bhatti MZ, Shah AS, Duong HQ,
Alkreathy HM, Mohammad SF, Khan RA and Ahmad A: Tumor-suppressive
p53 signaling empowers metastatic inhibitor KLF17-dependent
transcription to overcome tumorigenesis in non-small cell lung
cancer. J Biol Chem. 290:21336–21351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ali A, Zhang P, Liangfang Y, Wenshe S,
Wang H, Lin X, Dai Y, Feng XH, Moses R, Wang D, et al: KLF17
empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway
to suppress tumor growth and metastasis during cancer progression.
Cell Death Dis. 6:e16812015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai XD, Zhou YB, Huang LX, Zeng QL, Zhang
LJ, Wang QQ, Li SL, Feng JQ and Han AJ: Reduced expression of
Kruppel-like factor 17 is related to tumor growth and poor
prognosis in lung adenocarcinoma. Biochem Biophys Res Commun.
418:67–73. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ye WC, Gao L, Huang J, Fang XM and Xie G:
Suppressed Krüppel-like factor 17 expression induces tumor
proliferation, metastasis and a poor prognosis in papillary thyroid
carcinoma. Mol Med Rep. 10:2087–2092. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Milone MC and O'Doherty U: Clinical use of
lentiviral vectors. Leukemia. 32:1529–1541. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stuelten CH, Parent CA and Montell DJ:
Cell motility in cancer invasion and metastasis: Insights from
simple model organisms. Nat Rev Cancer. 18:296–312. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Campbell K: Contribution of
epithelial-mesenchymal transitions to organogenesis and cancer
metastasis. Curr Opin Cell Biol. 55:30–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou S, Tang X and Tang F: Krüppel-like
factor 17, a novel tumor suppressor: Its low expression is involved
in cancer metastasis. Tumour Biol. 37:1505–1513. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu FY, Deng YL, Li Y, Zeng D, Zhou ZZ,
Tian DA and Liu M: Down-regulated KLF17 expression is associated
with tumor invasion and poor prognosis in hepatocellular carcinoma.
Med Oncol. 30:4252013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sachdeva M, Dodd RD, Huang Z, Grenier C,
Ma Y, Lev DC, Cardona DM, Murphy SK and Kirsch DG: Epigenetic
silencing of Kruppel like factor-3 increases expression of
pro-metastatic miR-182. Cancer Lett. 369:202–211. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feinberg AP: The key role of epigenetics
in human disease prevention and mitigation. N Engl J Med.
378:1323–1334. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim KB, Son HJ, Choi S, Hahm JY, Jung H,
Baek HJ, Kook H, Hahn Y, Kook H and Seo SB: H3K9 methyltransferase
G9a negatively regulates UHRF1 transcription during leukemia cell
differentiation. Nucleic Acids Res. 43:3509–3523. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Taniue K, Kurimoto A, Sugimasa H, Nasu E,
Takeda Y, Iwasaki K, Nagashima T, Okada-Hatakeyama M, Oyama M,
Kozuka-Hata H, et al: Long noncoding RNA UPAT promotes colon
tumorigenesis by inhibiting degradation of UHRF1. Proc Natl Acad
Sci U S A. 113:1273–1278. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mudbhary R, Hoshida Y, Chernyavskaya Y,
Jacob V, Villanueva A, Fiel M, Chen X, Kojima K, Thung S, Bronson
RT, et al: UHRF1 overexpression drives DNA hypomethylation and
hepatocellular carcinoma. Cancer Cell. 25:196–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
